Following its strategic plan, STRAX now has secured an investment of EUR10m from ZEBRA Invest GmbH, ...
Redeye is encouraged to see yet another quarter in which BONESUPPORT positively surprises us.
Redeye lowers its fair value range following the updated FDA timeline, which will likely hold the sh...
• We cut '23e-'25e adj. EBITA by 12-6% • Negative price/mix from inflation data continues • Trading ...
• Cost initiatives announced • One step closer to positive FCF • Trading at '23e EV/EBITDA of ~21x W...
Inför Q2-rapporten räknar Analysguiden med en lönsamhet under press men något ökad omsättning.
Redeye konstaterar att BioArctics rapport för det andra kvartalet kom in i linje med för förväntan, ...
• Adj. EBITA SEK 210m (-9% vs. ABGSCe 231m) • Cons.
Redeye comments on Coala Life's directed issue of cSEK17m.
• Q2 report due on Thursday, 20 July • Sequential earnings growth to continue, but down y-o-y • H2 c...
Migrationen av de nya kunderna slutförd Migrationen av Lunars P2P-kunder har gått bra och redan i mi...
Redeye comments on the latest information regarding Karpatens lawsuit.
Redeye provides its commentary on Coala Life based on the recently released Key Performance Indicato...
• Solid Q2 report, NAV down on MFG • Recent increase in interest rate expectations • 2023e P/CEPS at...
Yesterday (10 July), Scanfil upgraded the midpoint of its full-year revenue guidance by 2%.
Redeye shares its preview of BONESUPPORT’s Q2 2023e results, due July 13.
Redeye is encouraged to see that Flexion Mobile is partnering with Xiaomi by adding another distribu...
- Positive net letting and higher rental levels - Floating debt with higher interest rates takes do...
- Retailers' underlying operations still weak... - .
